Dr Penny Hundleby
GM technologies are used not only to create commercial GM crops but they are widely exploited as a research tool for testing gene function. Brassicas in both the form of oilseed rape and as vegetable crops have an annual UK market value in excess of £800M. There is therefore great interest in gaining a better understanding of the genetics of these crops, especially the role of genes with potential use in crop improvement. My job primarily involves co-ordinating the Brassica transformation programmes at JIC, facilitating the translation of findings from model plants into Brassica. This work involves collaborations with many different scientists both locally and globally through my role within BRACT (Biotech Resources for Arable Crop Transformation (www.bract.org) a transformation facility based at the JIC.
I also have as strong interest in the current state of play regarding GM crops on a global level, with a special interest in GM regulation at the EU level. I am also a serving committee member (communications officer) for the International Society for Plant Molecular Farming (http://www.societyformolecularfarming.org/)
Field trials and tribulations-making sense of the regulations for experimental field trials of transgenic crops in Europe.
Plant Biotechnology Journal 10 p511-523
Publisher’s version: 10.1111/j.1467-7652.2012.00681.x
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plantsMa, Julian; Drossard, Jürgen; Lewis, David; Altmann, Friedrich; Boyle, Julia; Christou, Paul; Cole, Tom; Dale, Philip; van D
Plant Biotechnology Journal 13 p11061120
Publisher’s version: 10.1111/pbi.12416
Critical Reviews in Biotechnology 1 p1-9
Publisher’s version: 10.3109/07388551.2015.1055707
Current Pharmaceutical Design 19 p5513-5530